1. Medtech Insight
  2. >>Policy & Regulation

US Medicare Payment Schedule Targets Mental Health And Underserved Areas

 
• By Brian Bossetta

In its physician fee schedule for 2023, US Medicare seeks to expand access to mental health services and overall care to patients in rural and underserved communities.

MEDICARE BUTTONS
• Source: Shutterstock

The US Centers for Medicare and Medicaid Services (CMS) has outlined a series of proposals in its physician fee schedule (PFS) proposed rule for calendar year 2023 that broaden access for mental health and overall health care for rural Americans and those in traditionally underserved communities, such as expanded cancer screenings and dental coverage.

Though the 2023 PFS, to be published in the Federal Register 29 July, would lead to physician reimbursement cuts – decreasing the conversion factor by $1.53 from $34.61 in 2022 to $33

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

Debate On FDA User Fee Reauthorization Begins To Take Shape

 
• By Elizabeth Orr

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.

Health Secretary Defends Spending Cuts During Senate Hearing On HHS Budget

 
• By Elizabeth Orr

Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 
• By Brian Bossetta

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.

Califf Warns Progress May Be In Danger Due To ‘Decimated’ FDA Staff

 
• By Barnaby Pickering

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.

More from Medtech Insight